Diabetes Metab 43(5):430437 Nslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ et al (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men
2025;9(5):e2401171
Apparently, that came in the form of a huge government-mediated discount on the blockbuster weight loss drugs known as GLP-1s, like Wegovy and Zepbound
If you're sensitive to gastrointestinal effects, a morning injection might make morning meetings or errands more challenging
Key Companies Innovating in GLP-1 Obesity Treatments In 2025, the landscape of obesity treatment is being reshaped by innovative companies developing GLP-1 (glucagon-like peptide-1) receptor agonists
Same-Day Doctor Visits: It offers same-day access to a doctor